Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02868593
Other study ID # 2013-47
Secondary ID 2013-A01538-37
Status Recruiting
Phase N/A
First received August 11, 2016
Last updated August 11, 2016
Start date January 2014
Est. completion date June 2017

Study information

Verified date August 2016
Source Assistance Publique Hopitaux De Marseille
Contact Michel DRANCOURT
Phone 04 91 38 55 19
Email michel.drancourt@ap-hm.fr
Is FDA regulated No
Health authority France: Agence Nationale de Sécurité du Médicament et des produits de santé
Study type Interventional

Clinical Trial Summary

The primary purpose of this study is to assess the contribution of a non-invasive sampling (pharyngeal swab) in the diagnosis of community based meningitis or meningo-encephalitis.


Description:

Community-based meningitis and meningo-encephalitis are defined by the presence of more than 10 leukocytes per mL of cerebrospinal fluid (CSF), eventually reported to the number of red blood cells. They can be associated with encephalitis, defined by cerebral or cerebellar dysfunction in the case of the transmission. The evolution includes death, what makes the seriousness of this clinical situation. However the diagnostic performance of meningitis and meningo-encephalitis in a patient without contact with a care structure is less than 25% resulting in empirical support in half of the patients. Indeed, the microbiological diagnosis of meningitis and transmission target currently only five pathogens including HIV positive resulted in a significant change to support the patient in three areas, decision of hospitalization, decision of isolation and antibiotic or antiviral treatment decision. A weekly epidemiological monitoring of the microbiological diagnosis of meningitis and meningo-encephalitis has enabled us to see a mismatch between a curve of requests for analyses and a flat curve of produced diagnoses. This discrepancy is interpreted as indicating a community outbreak of meningitis or meningo-encephalitis non-diagnosed by routine methods, called orphan meningitis or orphan meningo-encephalitis. On this observation, our research project is to improve the performance of the etiological diagnosis of community-based meningitis or meningo-encephalitis. To do this, we will evaluate the diagnostic performance of an advanced technique, using a non-invasive sample, the pharyngeal swab from the patient, to find micro-organisms that are not part of the commensal flora of the pharynx and who are responsible for undetected in routine meningitis. Indeed the main pathogens and meningitis (enterovirus, pneumococcus, meningococcus) transmission give a pharyngeal carriage before being responsible for meningitis or meningo-encephalitis. These bacteria are Coxiella burnetii, Bartonella spp., Tropheryma whipplei, Leptospira spp. and Borrelia spp.


Recruitment information / eligibility

Status Recruiting
Enrollment 1800
Est. completion date June 2017
Est. primary completion date January 2017
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patient is aged more than 18 years old.

- Patient with clinical meningitis or meningo-encephalitis with community transmission.

- Patient with a prescription of microbiological diagnosis of meningitis or meningo-encephalitis.

- Patient who do not declined to have his medical records reviewed for research

- Patient with health insurance

Exclusion Criteria:

- Minor Patient (age <18 years)

- Pregnant woman, parturient or breastfeeding

- Adult Patient under guardianship

- Patient deprived of liberty under court order

- Patient vital in emergency.

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Intervention

Other:
Pharyngeal swab


Locations

Country Name City State
France Assistance Publique Hopitaux de Marseille Marseille

Sponsors (1)

Lead Sponsor Collaborator
Assistance Publique Hopitaux De Marseille

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Percentage of patients with established etiological diagnosis of community based meningitis or meningo-encephalitis 1 day No
See also
  Status Clinical Trial Phase
Completed NCT03226379 - Driving Reduced AIDS-associated Meningo-encephalitis Mortality N/A